Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 9567498, 5 pages
https://doi.org/10.1155/2017/9567498
Research Article

Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds

1Section of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari, 11 Piazza Giulio Cesare, 70124 Bari, Italy
2Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, 11 Piazza Giulio Cesare, 70124 Bari, Italy

Correspondence should be addressed to Michelangelo Vestita; moc.liamg@atitsevolegnalehcim

Received 15 September 2016; Revised 13 December 2016; Accepted 24 January 2017; Published 15 February 2017

Academic Editor: François Berthiaume

Copyright © 2017 Giuseppe Giudice et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Raw data of the two studied groups of burn patients (treated with either Nexobrid or standard of care) used for direct cost assessment as well as for confidence interval analysis.

  1. Supplementary Material